Pediatric Sepsis Phenotypes and Outcome: 5-Year Retrospective Cohort Study in a Single Center in India (2017-2022)

Pediatr Crit Care Med. 2024 Apr 1;25(4):e186-e192. doi: 10.1097/PCC.0000000000003449. Epub 2024 Feb 2.

Abstract

Objectives: To describe mortality associated with different clinical phenotypes of sepsis in children.

Design: Retrospective study.

Setting: PICU of a tertiary care center in India from 2017 to 2022.

Patients: Six hundred twelve children (from 2 mo to 17 yr old) with a retrospectively applied diagnosis of sepsis using 2020 guidance.

Methods: The main outcome was mortality associated with sepsis subtypes. Other analyses included assessment of risk factors, requirement for organ support, and PICU resources used by sepsis phenotype. Clinical data were recorded on a predesigned proforma.

Interventions: None.

Measurements and results: Of the 612 children identified, there were 382 (62%) with sepsis but no multiple organ failure (NoMOF), 48 (8%) with thrombocytopenia-associated MOF (TAMOF), 140 (23%) with MOF without thrombocytopenia, and 40 (6.5%) with sequential MOF (SMOF). Mortality was higher in the SMOF (20/40 [50%]), MOF (62/140 [44%]) and TAMOF (20/48 [42%]) groups, compared with NoMOF group (82/382 [21%] [ p < 0.001]). The requirement for organ support and PICU resources was higher in all phenotypes with MOF as compared with those without MOF. On multivariable analysis elevated lactate and having MOF were associated with greater odds of mortality.

Conclusions: In this single-center experience of sepsis in India, we found that sepsis phenotypes having MOF were associated with mortality and the requirement of PICU resources. Prospective studies in different regions of the world will help identify a classification of pediatric sepsis that is more widely applicable.

MeSH terms

  • Child
  • Humans
  • India / epidemiology
  • Infant
  • Intensive Care Units, Pediatric
  • Phenotype
  • Prospective Studies
  • Retrospective Studies
  • Sepsis* / diagnosis
  • Thrombocytopenia* / complications
  • Thrombocytopenia* / epidemiology